ABSI Stock Analysis: Buy, Sell, or Hold?

ABSI - Absci Corporation Common Stock

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
$2.99
-0.04 (-1.32%) ▼
HOLD
MODERATE Confidence
Protect Your ABSI Gains
Last Updated: January 30, 2026
Earnings: Mar 17, 2026

Get Alerted When ABSI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ABSI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: ABSI is currently trading at $2.99, which is considered oversold relative to its 30-day fair value range of $3.01 to $3.64.

Technical Outlook: Technically, ABSI is showing sideways momentum. Immediate support is located at $2.85, while resistance sits at $3.19.

Market Sentiment: ABSI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.05 (+165.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $3.01 - $3.64
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

Protect Your Profits

Holding ABSI? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 165.5% below Wall St target ($8.05)

Fair Price Analysis

30-Day Fair Range $3.01 - $3.64
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $2.85
Resistance Level $3.20
Current Trend Sideways

Fundamental Context

Forward P/E (Next Year Est.) -4.30
Wall Street Target $8.05 (+165.5%)
Revenue Growth (YoY) -77.8%
Last updated: January 30, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Menelas N Pangalos BUY 95785 shares 2025-09-22
Todd Bedrick BUY 10000 shares 2025-09-22

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$21 54 HOLD
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$486 45 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$500 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$91 64 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$830 52 HOLD

Advanced ABSI Option Strategies

Professional options setups generated by AI based on today's ABSI price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ABSI

ABSI Technical Chart ABSI Price Prediction ABSI Earnings Date ABSI Investment Advisor ABSI Fair Price Analyzer ABSI Options Advisor ABSI Options Chain ABSI Options Analysis ABSI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals